... treatment only after dissemination with that of patients who received initial adjuvant therapy. Results: After adjuvant treatment, survival in patients with disseminated breast cancer is up to a third shorter than that of patients without adjuvant therapy. Conclusions: In accordance with published evidence...

... developed multifocal leucencephalopathy, 2 patients fell into coma. Conclusions: As the Stuttgart study could not include a control group of patients who had undergone surgery only, the study is not able to proof the possible ineffectiveness of an adjuvant therapy with levamisole and 5-FU. Considering...

...G. Hartung; P. Diezler; E. Hagmüller; W. Queißer In this review new approaches to adjuvant therapy of colon and rectum carcinomas are reported. Early trials in the 70s using 5-fluorouracil and other monotherapies did not show any advantage for prognosis. The use of combination chemotherapy (e.g. 5...

... has a beneficial effect on plasma lipid metabolism as well as bone metabolism. Comprising the beneficial effects of tamoxifen, the possibility and feasibility of breast cancer prevention in a high-risk population were to be evaluated. Breast cancer Risk factors Tamoxifen Adjuvant therapy Breast...

... Conference on risk-adapted adjuvant therapy, treatment recommendations have been made for node-positive and -negative patients. Node-negative patients were divided into minimal-, low-, and high-risk groups. Except for minimal-risk situation, adjuvant systemic treatment was recommended for all women...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Combined modality treatment Gastric carcinoma Adjuvant therapy...